Finally, survival analysis using GEPIA and the NPC dataset GES102349 demonstrated that higher FOXD1 expression significantly correlated with poorer overall survival (OS) (Fig. 1C). This evidence concerns the gene FOXD1 and nasopharyngeal carcinoma.